The regulation of vascular endothelial growth factor A (VEGF) is critical to
neovascularization in numerous tissues under physiological and pathological conditions …

Despite extensive research, pro-angiogenic drugs have failed to translate clinically, and
therapeutic angiogenesis, which has potential in the treatment of various cardiovascular …

Vascular endothelial growth factor (VEGF) is a major target for the inhibition of tumour
vascularisation and the treatment of human cancer. Many tumours produce large quantities …

Introduction‐Angiogenesis in physiology and pathology‐Angiogenesis in current medicine‐
VEGF ligand and receptor system: where does sVEGFR1 fit?‐Ligands: the human VEGF …

Stroke is a leading cause of death and disability worldwide. Ischemic stroke is the dominant
subtype of stroke and results from focal cerebral ischemia due to occlusion of major cerebral …

Several cytokine families have roles in the development, maintenance, and remodeling of
the microcirculation. Of these, the vascular endothelial growth factor (VEGF) family is one of …

This article aims to promote integration of angiogenesis-related models, both integration of
the work described herein and many other existing and future models. Integration of …

Background Angiogenesis is a process by which new capillaries are formed from pre-
existing blood vessels in physiological (eg, exercise, wound healing) or pathological (eg …

Recent advances in cancer research have identified critical angiogenic signaling pathways
and the influence of the extracellular matrix on endothelial cell migration. These findings …

Ischaemia‐induced skeletal muscle angiogenesis is impaired in aged compared with young
mice. In humans, vascular endothelial growth factor (VEGF) mRNA and protein following an …